Michael E. Lewis, Chief Scientific Advisor at Cara Therapeutics, Inc. (CARA), sold 7,262 shares at $9.90 ($72K) on 2015-04-01, disclosed to the SEC on 2015-04-02.
Scheduled sale ($72k) by Chief Scientific Advisor under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2015-06-02 | $69K | — | Filing → |
| CARA | SELL | 2015-05-05 | $77K | — | Filing → |
| CARA | SELL | 2015-03-03 | $73K | — | Filing → |